Square Pharmaceuticals (DHA:SQURPHARMA) Change In Other Working Capital : BDT1,302 Mil (TTM As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Square Pharmaceuticals Change In Other Working Capital?

Square Pharmaceuticals's Change In Other Working Capital for the quarter that ended in Mar. 2025 was BDT280 Mil. It means Square Pharmaceuticals's Other Working Capital increased by BDT280 Mil from Dec. 2024 to Mar. 2025 .

Square Pharmaceuticals's Change In Other Working Capital for the fiscal year that ended in Jun. 2024 was BDT1,000 Mil. It means Square Pharmaceuticals's Other Working Capital increased by BDT1,000 Mil from Jun. 2023 to Jun. 2024 .

Square Pharmaceuticals Change In Other Working Capital Historical Data

The historical data trend for Square Pharmaceuticals's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Square Pharmaceuticals Change In Other Working Capital Chart

Square Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Change In Other Working Capital

Get a 7-Day Free Trial

270.46

-107.72

503.34

144.81

1,000.34

Square Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Other Working Capital	Get a 7-Day Free Trial															-2,794.43	564.34	1,397.61	-939.47	279.88

Square Pharmaceuticals Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT1,302 Mil.

Square Pharmaceuticals Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Square Pharmaceuticals's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Square Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Square Pharmaceuticals PLC (DHA:SQURPHARMA) » Definitions » Change In Other Working Capital

Traded in Other Exchanges

N/A

Address

Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212

Website

https://www.squarepharma.com.bd

Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs for health care for all living species. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. Company also provides devices such as AnsuPen and AnsuPen Twist. The company operates in Bangladesh and sells its products locally and internationally.

Square Pharmaceuticals Headlines

No Headlines